Particle Sciences expands operations by acquiring new additional space

Particle Sciences Inc., a leading pharmaceutical CRO, has further expanded their capabilities by the acquisition of additional space bringing their total to approximately 21,000 sq ft. "Our current workload and existing pipeline simply necessitates this addition," says Dr. Mark Mitchnick, CEO. "2009 has been a record year for us and we have pretty good visibility on the next 12 months.

The additional space will be used to expand our cGMP warehouse capacity. Also, we will construct a purpose-built sampling and weighing area for highly potent materials," says Mitchnick. According to Robert Lee, PhD, Particle Sciences VP of Pharmaceutical Development, "Increasingly, clients are coming to us for clinical trial material manufacturing and to work with a greater number of highly potent compounds. We are fortunate that we are able to expand into both of those needs." Particle Sciences expects the new space to be operational in Q1 2010.